SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-001101
Filing Date
2023-10-03
Accepted
2023-10-03 16:05:11
Documents
12
Period of Report
2023-09-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea186256-8k_chinapharma.htm   iXBRL 8-K 24585
  Complete submission text file 0001013762-23-001101.txt   199334

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cphi-20230927.xsd EX-101.SCH 3024
3 XBRL LABEL FILE cphi-20230927_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cphi-20230927_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT ea186256-8k_chinapharma_htm.xml XML 3423
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 231303484
SIC: 2834 Pharmaceutical Preparations